Cephalexin recalls

The FDA has published 20 recalls involving Cephalexin since 2014. The latest was reported on 18 Jun 2025. Most were for potency & assay. Ascend Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls20since 2014
Last 12 months0reported
Class I00% of total
Ongoing8latest 18 Jun 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 15 75%Class III 5 25%

By year

Ongoing cephalexin recalls

8 active

All cephalexin recalls, newest first

20 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IICephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 125mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 250mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 250mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 250mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 125mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IICephalexin for Oral Suspension, Generic for Keflex recalledCephalexinPreferred PharmaceuticalsPotency & AssayCA
DrugCLASS IICephalexin for Oral Suspension, USP 250 mg per (when mixed) recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP 250 mg per (when mixed) recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP, 125 mg recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP 250 mg per (when mixed) recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP 250 mg per (when mixed) recalledCephalexinAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP 250 mg recalledCephalexinTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IICephalexin for Oral Suspension, USP 125 mg recalledCephalexinTeva Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IICephalexin for Oral Suspension, USP 250 mg recalledCephalexinTeva Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IICephalexin for Oral Suspension USP 250mg recalledCephalexinLupin PharmaceuticalsForeign MaterialNationwide
DrugCLASS IICephalexin Monohydrate Capsules,USP, 500 mg recalledPhysicians Total CareManufacturing (CGMP) DeviationsGA, MO
DrugCLASS IICephalexin Capsules, USP, 500 mg recalled by Caraco PharmaceuticalCaraco Pharmaceutical LaboratoriesManufacturing (CGMP) DeviationsNationwide
DrugCLASS IICephalexin Capsules, USP, 250 mg recalled by Caraco PharmaceuticalCaraco Pharmaceutical LaboratoriesManufacturing (CGMP) DeviationsNationwide

Should you stop taking Cephalexin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.